METACARE CO., Ltd. (KRX:118000)
1,760.00
-40.00 (-2.22%)
May 21, 2026, 3:30 PM KST
METACARE CO. Market Cap
METACARE CO. has a market cap or net worth of 30.92 billion as of May 20, 2026. Its market cap has decreased by -40.43% in one year.
Market Cap
30.92B
Enterprise Value
89.98B
Revenue
32.82B
Ranking
n/a
PE Ratio
60.87
Stock Price
1,760.00
Market Cap Chart
Since January 4, 2010, METACARE CO.'s market cap has decreased from 39.82B to 30.92B, a decrease of -22.35%. That is a compound annual growth rate of -1.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 20, 2026 | 30.92B | -40.98% |
| Dec 30, 2025 | 52.39B | 12.75% |
| Dec 30, 2024 | 46.47B | -18.64% |
| Dec 28, 2023 | 57.11B | 29.66% |
| Dec 29, 2022 | 44.05B | -64.01% |
| Dec 30, 2021 | 122.39B | -14.64% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 64.16T |
| Celltrion | 38.25T |
| ALTEOGEN | 19.61T |
| Samsung Epis Holdings | 11.92T |
| EOFLOW | 51.11B |
| Tdspharm | 46.18B |
| Aprogen Biologics | 44.39B |
| BCWORLD PHARM. | 42.19B |